BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8823257)

  • 1. A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22.
    Scarantino CW; Caplan R; Rotman M; Coughlin C; Demas W; Delrowe J
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):37-48. PubMed ID: 8823257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA).
    Salazar OM; Sandhu T; da Motta NW; Escutia MA; Lanzós-Gonzales E; Mouelle-Sone A; Moscol A; Zaharia M; Zaman S
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):765-75. PubMed ID: 11395246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.
    Poulter CA; Cosmatos D; Rubin P; Urtasun R; Cooper JS; Kuske RR; Hornback N; Coughlin C; Weigensberg I; Rotman M
    Int J Radiat Oncol Biol Phys; 1992; 23(1):207-14. PubMed ID: 1374061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose.
    Salazar OM; DaMotta NW; Bridgman SM; Cardiges NM; Slawson RG
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):49-60. PubMed ID: 8823258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report.
    Salazar OM; Rubin P; Hendrickson FR; Komaki R; Poulter C; Newall J; Asbell SO; Mohiuddin M; Van Ess J
    Cancer; 1986 Jul; 58(1):29-36. PubMed ID: 2423225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Half body irradiation of patients with multiple bone metastases: a phase II trial.
    Berg RS; Yilmaz MK; Høyer M; Keldsen N; Nielsen OS; Ewertz M
    Acta Oncol; 2009; 48(4):556-61. PubMed ID: 18979285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
    Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
    Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
    Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: report of a 10-year experience.
    Bashir FA; Parry JM; Windsor PM
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):591-8. PubMed ID: 18562185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
    Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
    Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.
    Macchia G; Ferro M; Cilla S; Buwenge M; Ianiro A; Boccardi M; Picardi V; Ferro M; Arena E; Zamagni A; Cammelli S; Valentini V; Morganti AG; Deodato F
    Clin Exp Metastasis; 2018 Dec; 35(8):747-752. PubMed ID: 30251079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).
    Ryu JK; Winter K; Michalski JM; Purdy JA; Markoe AM; Earle JD; Perez CA; Roach M; Sandler HM; Pollack A; Cox JD
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1036-46. PubMed ID: 12419429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-fractionated wide-field radiation therapy for palliation of multiple symptomatic bone metastases from solid tumors.
    Hayashi S; Hoshi H; Iida T; Kajiura Y
    Radiat Med; 1999; 17(6):411-6. PubMed ID: 10646976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
    Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
    J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative hemibody irradiation in hormonally refractory metastatic prostate cancer.
    Nseyo UO; Fontanesi J; Naftulin BN
    Urology; 1989 Aug; 34(2):76-9. PubMed ID: 2474883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficiency and tolerance of half-body irradiation (HBI) in patients with multiple metastases. The Krakow experience.
    Skolyszewski J; Sas-Korczynska B; Korzeniowski S; Reinfuss M
    Strahlenther Onkol; 2001 Sep; 177(9):482-6. PubMed ID: 11591022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
    Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.